Arkadios Wealth Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.1% in the 4th quarter, ...
Danaher Corp (DHR) stock saw a decline, ending the day at $238.36 which represents a decrease of $-3.54 or -1.46% from the prior close of $241.9. The stock opened at $242.17 and touched a low of $238.
Danaher Corp. closed $44.08 short of its 52-week high ($281.70), which the company achieved on August 1st.
Shares of Danaher Corp. DHR advanced 1.65% to $241.90 Thursday, on what proved to be an all-around dismal trading session for ...
Danaher executed a $4.5 billion share buyback, with an additional 20 million shares authorized. Learn why I remain bullish on ...
Senator Elizabeth Warren has called on President-elect Trump's defense secretary pick, Pete Hegseth, to divest from thousands ...
Assenagon Asset Management S.A. trimmed its stake in Danaher Co. (NYSE:DHR – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange ...
Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve ...
Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2024 performance in a ...
As of 2025-01-17, Danaher Corp's intrinsic value as calculated by the Discounted Earnings model is $131.19. It's currently trading at a price of $241.9. Therefore, the margin of safety based on ...
Danaher Corp. (DHR) said it expects non-GAAP core revenue for the fourth quarter of 2024 to be essentially flat year-over-year, ...
In a report released today, Luke Sergott from Barclays maintained a Hold rating on Danaher (DHR – Research Report), with a price target of ...